Magnesium sulfate for aneurysmal subarachnoid hemorrhage: The end of the road or more trials?

Critical Care

Volumn 15, Issue 2, 2011, Pages

  Vergouwen, Mervyn D I ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

MAGNESIUM SULFATE; PLACEBO; NEUROPROTECTIVE AGENT;

ARTICLE; BRAIN ARTERY ANEURYSM; BRAIN INFARCTION; BRAIN ISCHEMIA; BRAIN VASOSPASM; CLINICAL PROTOCOL; DELAYED BRAIN ISCHEMIA; DETERIORATION; DRUG EFFICACY; HUMAN; META ANALYSIS (TOPIC); OUTCOME ASSESSMENT; PRIORITY JOURNAL; RISK REDUCTION; SAMPLE SIZE; SUBARACHNOID HEMORRHAGE; SYSTEMATIC REVIEW (TOPIC); NOTE;

HUMANS; MAGNESIUM SULFATE; NEUROPROTECTIVE AGENTS; SUBARACHNOID HEMORRHAGE;

EID: 84856171308     PISSN: 13648535     EISSN: 1466609X     Source Type: Journal    
DOI: 10.1186/cc10055     Document Type: Article

References (6)

1. Wong GKC, Boet R, Poon WS, Chan MTV, Gin T, Ng SCP, Zee BCY. Intravenous magnesium sulphate for aneurysmal subarachnoid hemorrhage: an updated systemic review and meta-analysis. Crit Care 2011, 15:R52. 10.1186/cc10017, 21299874.
2. Wong GK, Poon WS, Boet R, Chan MT, Gin T, Ng SC, Zee B, . IMASH investigators Intravenous magnesium sulphate after aneurysmal subarachnoid hemorrhage: a multi-center phase III study. Stroke 2010, 41:921-926. 10.1161/STROKEAHA.109.571125, 20378868, IMASH investigators.
3. Westermaier T, Stetter C, Vince GH, Pham M, Tejon JP, Eriskat J, Kunze E, Matthies C, Ernestus RI, Solymosi L, Roosen K. Prophylactic intravenous magnesium sulfate for treatment of aneurysmal subarachnoid hemorrhage: a randomized placebo-controlled, clinical study. Crit Care Med 2010, 38:1284-1290. 10.1097/CCM.0b013e3181f17878, 20228677.
4. Vergouwen MD, Vermeulen M, van Gijn J, Rinkel GJ, Wijdicks EF, Muizelaar JP, Mendelow AD, Juvela S, Yonas H, Terbrugge KG, Macdonald RL, Diringer MN, Broderick JP, Dreier JP, Roos YB. Definition of delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage as an outcome event in clinical trials and observational studies: proposal of a multidisciplinary research group. Stroke 2010, 41:2391-2395. 10.1161/STROKEAHA.110.589275, 20798370.
5. Elmina N, Vergouwen MD, Lodge D, Macdonald RL. Effect of pharmaceutical treatment on vasospasm, delayed cerebral ischemia, and clinical outcome in patients with aneurysmal subarachnoid hemorrhage: a systematic review and meta-analysis. J Cereb Blood Flow Metab 2011,
6. Dorhout Mees SM, . MASH-II study group Magnesium in aneurysmal subarachnoid hemorrhage (MASH II) phase III clinical trial MASH-II study group. Int J Stroke 2008, 3:63-65. 10.1111/j.1747-4949.2008.00168.x, 18705917, MASH-II study group.